HealthCall

Technology-based extension of motivational interviewing to reduce non-injection drug use in HIV primary care patients – a pilot study

Bibliographic Data

ID19439002
AuthorsEfrat Aharonovich (0000-0002-3423-5786, Columbia University), Eliana Greenstein (b New York State Psychiatric Institute , New York , NY , USA), Ann O’leary (0000-0001-8129-3121, Centers for Disease Control and Prevention), Ann O'Leary (c Centers for Disease Control , Atlanta , GA , USA), Barbara Johnston (0000-0002-3454-1660, d Mt. Sinai Hospital , New York , NY , USA), Simone G Seol (b New York State Psychiatric Institute , New York , NY , USA), Deborah S Hasin (0000-0002-6533-7021, Columbia University, corresponding author)
Year2012
Volume24
Issue12
Pages1461-1469
Publication date2012-12-01
Open AccessNo
TypeARTICLE
VenueAIDS Care (JOURNAL)
Journal identifiersISSN: 0954-0121 • E-ISSN: 1360-0451
PublisherInforma UK Limited (PUBLISHER • GB)
DOI10.1080/09540121.2012.663882
PMID22428809
PMCIDPMC3484210
OpenAlexW2081648743
LanguageEN
Citations received2
References cited28

To reduce non-injection drug use (NIDU) among HIV primary care patients, more than a single brief intervention may be needed, but clinic resources are often too limited for extended interventions. To extend brief motivational interviewing (MI) to reduce NIDU, we designed and conducted a pilot study of "HealthCall," consisting of brief (1-3 minutes) daily patient calls reporting NIDU and health behaviors to a telephone-based interactive voice response (IVR) system, which provided data for subsequent personalized feedback. Urban HIV adult clinic patients reporting ≥4 days of NIDU in the previous month were randomized to two groups: MI-only (n=20) and MI+HealthCall (n=20). At 30 and 60 days, patients were assessed and briefly discussed their NIDU behaviors with their counselors. The outcome was the number of days patients used their primary drug in the prior 30 days. Medical marijuana issues precluded HealthCall with patients whose primary substance was marijuana (n=7); excluding these, 33 remained, of whom 28 patients (MI-only n=17; MI+HealthCall n=11) provided post-treatment data for analysis. Time significantly predicted reduction in "days used" in both groups (p<0.0001). At 60 days, between-group differences approached trend level, with an effect size of 0.62 favoring the MI+HealthCall arm. This pilot study suggests that HealthCall is feasible and acceptable to patients in resource-limited HIV primary care settings and can extend patient involvement in brief intervention with little additional staff time. A larger efficacy trial of HealthCall for NIDU-reduction in such settings is warranted

Drug · Family medicine · Interview · Motivational interviewing · Physical therapy · Primary care · Psychiatry · Psychological intervention · Randomized controlled trial · HIV, Drug Use, Sexual Risk · HIV/AIDS Research and Interventions · Medicine · Mobile Health and mHealth Applications · Emergency Medicine · Internal Medicine

Tools

Open DOISci-Hub